Roivant spinoff Datavant is joining forces with medical data technology peer Ciox Health, which counts Merck & Co as an investor.
Two US-based, corporate backed companies – medical data exchange Datavant and healthcare data software provider Ciox Health – agreed to a merger yesterday valuing the joint business at $7bn.
Launched by biopharmaceutical company builder Roivant Sciences in 2017, Datavant provides software which helps businesses manage privacy, security and compliance for medical data repositories while sharing said data.
Datavant had raised a total of $83m as of a $40m series B round in October 2020 led by Transformation Capital and…
